News

Regeneron Pharmaceuticals recently reported earnings for Q1 2025 with a revenue drop to $3,029 million compared to the prior year, though net income increased, reflecting robust profitability with ...
We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst ...
Regeneron anticipates a decline in EYLEA sales due to biosimilar competition. DUPIXENT continues to expand globally, with significant growth expected by 2030. The company is investing $7 billion ...
We think investors are encouraged by the vagueness of the order and the significant room for negotiations. We sell different types of products and services to both investment professionals and ...
The latest price target for Regeneron Pharmaceuticals (NASDAQ:REGN) was reported by Citigroup on May 14, 2025. The analyst firm set a price target for $700.00 expecting REGN to rise to within 12 ...
Explore Regeneron Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REGN. Sanofi plans $20 billion US investment by 2030 to expand R&D and ...
As he put it, Maps was “a black Rubik’s Cube,” with obsessive lyrics about hiding inside codes, where you have to speak in cryptic riddles — “cover my tracks with backronyms ...
Naomi Watts celebrated Mother’s Day in New York City Sunday with her two kids and husband Billy Crudup. naomiwatts/instagram Naomi Watts celebrated Mother’s Day with her family in New York City.
When the lottery drawing was televised on ESPN, with the people inside the room already aware of the results, there was laughter when the broadcast announced that the Mavericks had moved into the ...
Sean "Diddy" Combs' federal trial began Monday after a jury of eight men and four women was seated. The 12-person jury and six alternates was only finalized minutes before opening statements began ...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other Jim Cramer stocks with huge upside potential. During the episode of Mad ...